About Ekf Diagnostics (LON:EKF)
EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.
Industry, Sector and Symbol
Industry Medical Monitoring Systems
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-0.90%
Return on Assets-0.49%
Ekf Diagnostics (LON:EKF) Frequently Asked Questions
What is Ekf Diagnostics' stock symbol?
Ekf Diagnostics trades on the London Stock Exchange (LON) under the ticker symbol "EKF."
Where is Ekf Diagnostics' stock going? Where will Ekf Diagnostics' stock price be in 2017?
1 Wall Street analysts have issued 1-year target prices for Ekf Diagnostics' shares. Their predictions range from GBX 21 to GBX 21. On average, they anticipate Ekf Diagnostics' share price to reach GBX 21 in the next year. View Analyst Ratings for Ekf Diagnostics.
Who are some of Ekf Diagnostics' key competitors?
Some companies that are related to Ekf Diagnostics include TSO3 (TOS), Trilogy International Partners (TRL), Faron Pharmaceuticals Oy (FARN), Corindus Vascular Robotics (CVRS), Mereo BioPharma Group (MPH), Zymeworks (ZYME), Minerva Neurosciences (NERV), Kindred Biosciences (KIN), AAC (AAC), Endocyte (ECYT), EndoChoice (GI), Vital Therapies (VTL), Cytosorbents (CTSO), Oncomed Pharmaceuticals (OMED), CRH Medical (CRHM), Recro Pharma (REPH), Kamada (KMDA) and Cogentix Medical (CGNT).
Who are Ekf Diagnostics' key executives?
Ekf Diagnostics' management team includes the folowing people:
- Julian Huw Baines, Chief Executive Officer, Executive Director (Age 50)
- Richard Anthony Evans, Finance Director, Chief Operating Officer, Executive Director (Age 57)
- Christopher Harwood Bernard Mills, Non-Executive Chairman of the Board (Age 64)
- David Eric Evans, Non-Executive Deputy Chairman of the Board
- Carl Dominic Contadini, Non-Executive Director (Age 67)
- Adam Reynolds, Independent Non-Executive Director (Age 53)
How do I buy Ekf Diagnostics stock?
Shares of Ekf Diagnostics and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Ekf Diagnostics' stock price today?
One share of Ekf Diagnostics stock can currently be purchased for approximately GBX 26.
How big of a company is Ekf Diagnostics?
Ekf Diagnostics has a market capitalization of £120.71 million.
How can I contact Ekf Diagnostics?
Ekf Diagnostics' mailing address is Avon HSE, 19 Stanwell Road, PENARTH, CF64 2EZ, United Kingdom. The company can be reached via phone at +44-29-20710570.
MarketBeat Community Rating for Ekf Diagnostics (EKF)MarketBeat's community ratings are surveys of what our community members think about Ekf Diagnostics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for Ekf Diagnostics (LON:EKF)
No earnings announcements for this company have been tracked by MarketBeat.com
Ekf Diagnostics (LON:EKF) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Ekf Diagnostics (LON:EKF)
No dividend announcements for this company have been tracked by MarketBeat.com
Ekf Diagnostics (LON EKF) Insider Trading and Institutional Ownership History
Ekf Diagnostics (LON EKF) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|10/3/2017||Christopher H B Mills||Insider||Sell||1,000,000||GBX 24||£240,000|
|3/20/2017||Christopher H B Mills||Insider||Buy||8,000,000||GBX 19||£1,520,000|
|7/15/2016||Mills,Christopher H B||Insider||Buy||9,000,000||GBX 15||£1,350,000|
|6/24/2016||Mills,Christopher H B||Insider||Buy||2,613,957||GBX 12||£313,674.84|
|6/23/2016||Mills,Christopher H B||Insider||Buy||2,000,000||GBX 12||£240,000|
|6/21/2016||Mills,Christopher H B||Insider||Buy||4,500,000||GBX 12||£540,000|
|6/17/2016||Mills,Christopher H B||Insider||Buy||532,781||GBX 12||£63,933.72|
|6/9/2016||Mills,Christopher H B||Insider||Buy||447,666||GBX 12||£53,719.92|
Ekf Diagnostics (LON EKF) News Headlines
|EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bearish Manner : EKF-GB : December 1, 2017|
finance.yahoo.com - December 1 at 5:16 PM
|EKF Diagnostics Holdings Plc :EKF-GB: Earnings Analysis: For the six months ended June 30, 2017 : November 9, 2017|
finance.yahoo.com - November 10 at 12:03 PM
|EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bearish Manner : EKF-GB : October 25, 2017|
finance.yahoo.com - October 25 at 8:01 PM
|Cancellation of escrow shares PDMR dealing/buyback - London South East (blog)|
www.lse.co.uk - October 5 at 5:26 PM
|EKF Diagnostics Holdings Plc – Value Analysis (LONDON:EKF) : October 5, 2017|
finance.yahoo.com - October 5 at 5:26 PM
|Christopher H. B. Mills Sells 1,000,000 Shares of Ekf Diagnostics Holding PLC (EKF) Stock|
www.americanbankingnews.com - October 4 at 10:42 AM
|EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bullish Manner : EKF-GB : October 4, 2017|
finance.yahoo.com - October 4 at 10:17 AM
|EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bearish Manner : EKF-GB : September 19, 2017|
finance.yahoo.com - September 19 at 6:13 PM
|EKF Diagnostics Trading In Line As It Swings To Interim Profit|
www.morningstar.co.uk - September 13 at 12:01 AM
|EKF Diagnostics Trading In Line As It Swings To Interim Profit - London South East (registration) (blog)|
www.lse.co.uk - September 11 at 11:48 PM
|Ekf Diagnostics Holding PLC (EKF) Receives Hold Rating from Panmure Gordon|
www.americanbankingnews.com - September 6 at 7:20 AM
|Ekf Diagnostics Holding PLC (EKF) Scheduled to Post Quarterly Earnings on Monday|
www.americanbankingnews.com - September 4 at 2:23 AM
|3 Hot Shares That Might Take Off In September|
finance.yahoo.com - September 1 at 6:33 PM
|Ekf Diagnostics Holding PLC's (EKF) corporate Rating Reiterated at N+1 Singer|
www.americanbankingnews.com - July 9 at 7:30 AM
|EKF Diagnostics Expects Full-Year Results Ahead Of Market Forecasts|
www.morningstar.co.uk - July 7 at 5:31 AM
|EKF Diagnostics Sees FY Adj EBITDA Ahead Of Market View; Stock Up|
www.rttnews.com - July 7 at 5:31 AM
|Cancellation of share options - London South East (registration) (blog)|
www.lse.co.uk - June 28 at 3:14 AM
|Hygea VCT plc : Update for the quarter ended 31 March 2017 - GlobeNewswire (press release)|
globenewswire.com - May 19 at 8:05 AM
|EKF Diagnostics Optimistic, Still Considering Potential Demerger - London South East (registration) (blog)|
www.lse.co.uk - May 11 at 5:35 PM
|Hygea VCT plc : Annual Report and Accounts and Notice of AGM|
globenewswire.com - April 10 at 4:43 PM
|The Top 50 Manufacturers of Hematology In-Vitro Diagnostics Analyzers, Reagents & Accessories Worldwide|
www.prnewswire.com - March 29 at 11:37 AM
|Full Year 2016 EKF Diagnostics Holdings PLC Earnings Release - Before Market Open|
biz.yahoo.com - March 20 at 7:39 PM
|This ‘special situation’ stock looks set to fly|
uk.finance.yahoo.com - March 20 at 7:39 PM
|Global Diabetes Diagnostics Industry - PR Newswire (press release)|
www.prnewswire.com - February 28 at 5:07 PM
|EKF Diagnostics 2016 Revenue Outpaces Previous Guidance|
www.morningstar.co.uk - January 9 at 5:45 PM
|Does EKF Diagnostics Holding plc have more upside than GlaxoSmithKline plc after beating expectations?|
uk.finance.yahoo.com - January 9 at 5:45 PM
|EKF Diagnostics FY16 Overall Performance To Exceed Revised Market Forecasts|
www.rttnews.com - January 9 at 2:46 AM
|Oryx International Growth Fund Net Assets Beat Benchmark In - London South East (registration) (blog)|
www.lse.co.uk - December 14 at 5:56 PM
|EKF Diagnostics Sees FY Results To Exceed Market View; Stock Climbs|
www.rttnews.com - October 7 at 4:44 PM
|Is Ekf Diagnostics Holding plc a buy as shares jump 10%+?|
uk.finance.yahoo.com - October 7 at 9:46 AM
Ekf Diagnostics (LON:EKF) SEC Filings
Financials are not available for this stock.
Ekf Diagnostics (LON EKF) Stock Chart for Monday, December, 11, 2017